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1. Introduction 
The replacement of segmental bone defects is still a challenge for 
orthopaedic surgeons, especially when the self-healing ability of the bone is 
compromised. Under such circumstances bone grafts often fail to 
incorporate into the host tissue leading to the development of nonunion. 
Currently, autogeneic bone grafts are known as the best for the replacement 
of bony defects because they are immunologically identical to the host, thus 
their incorporation is more secure than that of materials of foreign origin. 
Furthermore, the autogeneic bone grafts have innate biological and 
biophysical cues that are supposed to facilitate their fast incorporation. In 
spite of the beneficial properties the extensive clinical use of autografts is 
not possible owing to their limited availability, therefore there is an 
increasing need for donor bone (allograft) as a potent alternative of the 
autografts. Chemical sterilization and antigen extraction followed by freeze-
drying of bone allografts is a beneficial preparation method to reduce the 
risk of disease transmission and graft-versus-host reaction, thereby ensure 
the safe clinical use of the allografts. However, the chemical treatment may 
deteriorate the biological utility of the bone allografts reducing their 




 The main objective of the present doctoral work was to investigate 
and improve the in vitro and in vivo biocompatibility of chemically 
sterilized, antigen extracted, freeze-dried human bone grafts. 
 
Specific questions were: 
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2.1. Does the chemical treatment detrimentally affect the in vivo 
biocompatibility of freeze-dried human bone grafts?  
2.2. What coating substance and method would be sufficient to enhance the 
biological value of chemically sterilized, antigen extracted freeze-dried 
human bone grafts? 
2.3. How would the coating influence the in vitro and in vivo 
biocompatibility of the freeze-dried human bone grafts?  
 
3. Materials and methods 
3.1. Investigation of the in vivo biocompatibility of chemically sterilized, 
antigen extracted freeze-dried human bone graft 
 The animal experiment had been approved by the Local Committee 
of Animal Research Ethics. Male Wistar rats (Toxi-Coop, Hungary) 
weighing 500–600g were anesthetized with 1.5 L/min oxygen, 200cm3/min 
halothane (Sigma Aldrich, St Louis, MO). The tail was washed three times 
with braunol (Braun Medical, Bethlehem PA) and ligatured at the tail root 
for the prevention of bleeding. The tip of the tail was surgically removed 
after which a standardized defect was created by drilling through the distal 
side of the caudal vertebrae (C4-C5) by using a custom made drill with 2 
mm diameter, and with a shoulder at 3.5 mm to ensure a standardized depth. 
To prevent the self-regeneration of the vertebrae a stainless steel spacer was 
implanted into the drill hole. The wound was sutured and the animals were 
returned to their cages. After 12 weeks, the animals were anesthetized and 
the spacer was replaced. The cavital defect was filled either with PMMA 
(Heraeus Palacos R; n=5), premixed calcium phosphate cement (pCPC; 
n=5), Sr-doped calcium phosphate composite spheres (SrCPS; n=5), with 
impacted chemically sterilized, antigen extracted human freeze-dried bone 
chips (West Hungarian Regional Tissue Bank; n=5) or left empty (n=7), and 
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the wound was closed. At this time point a third group of animals (n=5) was 
added to serve as a positive control. Within this group, a defect was created 
as previously described, but the defect was left to heal normally without any 
spacer. The wound was closed by the same procedure as mentioned earlier. 
Twelve weeks later, all animals were over-anesthetized and euthanized by 
exsanguination. The last two vertebrae (last operated vertebra plus one 
healthy vertebra) were fixed in 4% formaldehyde and analyzed with µCT 
(Skyscan 1172 X-ray micro- tomography Skyscan, Kontich, Belgium) and 
histology.  
 The µCT scans were carried out applying a 60 kV voltage and an 
Al-filter. Reconstruction was done with a modified Feldkamp algorithm 
using Skyscan Nrecon software. The µCT reconstruction was obtained by 
rotating the view through 180 degrees (rotation step 0.5 degrees). SkyScan 
CTvox (Kontich, Belgium) was used for the 3D visualization.  
 Formaldehyde fixed vertebrae were decalcified by immersing them 
into Biodec-R solution for 1 week. Five micron longitudinal sections were 
cut from the paraffin blocks and mounted on glass slides. Conventional 
hematoxylin-eosin (Merck & Co) staining was used to confirm the results of 
the µCT measurements.  
 
3.2. In vitro experimental design 
 Three types of bone grafts, such as chemically sterilized, antigen 
extracted human cancellous bone allograft (West Hungarian Regional 
Tissue Bank), lyophilized bovine bone (BioOss, Geistlich Pharma AG) and 
synthetic hydroxyapatite (META BIOMED) were divided into three main 
experimental groups, i.e. control, Test A and Test B groups (Table 1).  
 Preparation of the chemically sterilized, antigen-extracted freeze-
dried allografts: the cadaveric bones were washed in methanol for 4 hours, 
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then they were digested in a solution of 0.1 M phosphate buffer saline, 
10mM sodium-azide and 10mM monoiodineacetic acid for 24 hours. Next, 
the bones were subjected to partial decalcification using 0.6 M HCl at room 
temperature for 4 to 6 hours. The as-produced human bone grafts were 
sterilized in ethylene-dioxide at 27°C, then they were freeze-dried 
aseptically (primer drying: 32°C, 2Pa, 12h; second drying: 32°C, 0Pa, 12h). 
 
 Test A and Test B groups were further divided into subgroups 
according to the method of coating, such as aqueous coating and freeze-
dried coating, respectively. As coating substances albumin of human serum 
origin (200g/1000ml, BIOTEST), fibronectin of human serum origin 
(20µg/ml, Sigma Aldrich), and 1,5% porcine type I collagen (Biom' up) 
were used. The albumin was diluted in 1:2 using phosphate buffered saline. 
As control, uncoated bone grafts were used in the experiments. In Test 
group A, the bone grafts were soaked into the aqueous solution of either 
human serum derived albumin or fibronectin or collagen and incubated at + 
4°C overnight. Upon the elapse of the incubation period the bone grafts 
were removed from the protein solutions and placed into cell culture dishes 
where mesenchymal stem cells (MSCs) were seeded onto their surfaces 
instantly. In Test group B, bone grafts were incubated overnight in aqueous 
solutions of the same proteins, as it was detailed in the case of Test group A. 
However, after overnight incubation the bone grafts were removed from the 
aqueous protein solution and they were freeze-dried at 32 °C, at 1 Pa for 24 
hours. After freeze-drying the bone grafts were placed into cell culture 
dishes where cells were seeded onto their surfaces immediately.  
 Samples before cell seeding were taken from each batch of Test A 
and Test B groups for mechanical and optical characterization. For 
mechanical characterization the Vickers hardness test method was applied, 
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while scanning electron microscopic images were acquired for structural 
characterization. The HV Vickers – hardness measurement is performed 
with a 136o angle of the vertex and square based diamond-pyramid. Flat 
surface areas were selected for micro-hardness measurement where the 
diamond-pyramid was pressed into with 50 g load weight for a period of 5 
seconds. On each sample at least five measurements were carried out, while 
the two diagonals of the impression and the micro-hardness values were 
measured and averaged. The numeric value (HV) of the Vickers – hardness 
was determined based on the following formula: the load force (F) explicit 
in Newton (N) was divided by the surface area (A) of the impression in 
mm2, and then the result was multiplied with a constant (C = 0,102). 
 The surface characteristic of the bone grafts was investigated by 
scanning electron microscopy (SEM) (Philips XL 30). An argentiferous 
adhesive was applied on the bottom of the samples that were coated with an 
electrically conductive gold layer using a vacuum-pulverisation method. 
The procedure was then performed in vacuum. The photographs were taken 
in the secunder electron (SE) mode with 15kV accelerating voltage. The 
secunder electrons are able to emerge from the uppermost layers, having a 
thickness of 5-50 nm, meaning that they are extremely sensitive to the 
disproportionate surface. The full surface area of the samples was 
investigated and representative microscopic images were acquired at 50x, 
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Table 1. In vitro experimental groups. In Test group A, the bone grafts were immersed into 
the aqueous solution of either human serum derived albumin (A) or fibronectin (B) or collagen 
(C). In Test group B, the bone grafts were incubated overnight in the aqueous solutions of the 
same proteins, which then were freeze-dried onto the surface of the bone grafts (α, β, γ). 
 Allograft BioOss Hydroxyapatite 
Control Uncoated Uncoated Uncoated 
Test A A) Aqueous albumin 
B) Aqueous fibronectin 
C) Aqueous collagen 
A) Aqueous albumin  
B) Aqueous fibronectin 
C) Aqueous collagen 
A) Aqueous albumin 
B) Aqueous fibronectin 
C) Aqueous collagen 
Test B α) Freeze-dried albumin 
β) Freeze-dried 
fibronectin 
γ) Freeze-dried collagen 
α) Freeze-dried albumin 
β) Freeze-dried fibronectin 
γ) Freeze-dried collagen 
α) Freeze-dried albumin 
β) Freeze-dried 
fibronectin 
γ) Freeze-dried collagen  
 
 Isolation of mesenchymal stem cells: Human bone marrow samples 
were obtained from young patients (aged 2-20) during standard orthopaedic 
surgical procedures, with the informed consent of the patients or their 
parents under approved ethical guidelines set by the Ethical Committee of 
the Hungarian Medical Research Council. Only such tissues were used that 
otherwise would have been discarded. The bone marrow was taken into T75 
flasks and diluted with Dulbecco’s Modified Eagle’s Medium culture 
medium containing 10% foetal calf serum (FCS), 100 U/ml penicillin and 
10 µg/ml streptomycin, 2mM L-glutamine and 1g/l glucose. The flasks were 
incubated at 37 °C in a fully humidified atmosphere of 5% CO2 for 3 days. 
After the incubation period the bone marrow derived mesenchymal stem 
cells (BMSCs) adhered to the surface of the flasks, the remaining 
components of bone marrow were eliminated by washing with phosphate-
buffered saline. The used BMSCs were between passages 1 and 5 in the 
experiments. The BMSCs were labelled with the fluorescent membrane dye 
Vybrant DiD (excitation/emission: 644/665 nm, Molecular Probes, 
Invitrogen, USA) for 30 minutes at 37°C in monolayer.  
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 The protocol that we followed for the isolation and culturing of 
dental pulp derived mesenchymal stem cells (DPSCs) was based on the 
procedure of Gronthos et al, however it was implemented with minor 
modifications in our experiment. Human impacted third molars were 
collected from adults (18–26 years of age). The tooth was cut around the 
cemento-enamel junction by sterile dental fissure burs to expose the pulp 
chamber. The pulp tissue had been removed from the crown and the roots 
then digested in a solution of collagenase type I (3 mg/ml) and dispase (4 
mg/ml) for 1 h at 37°C. Single-cell suspensions were obtained by passing 
the cells through a 70 µm strainer and were seeded into 6-well plates with 
alpha modification of Eagle’s medium (α-MEM) supplemented with 20% 
FCS, 100 µM L-ascorbic acid 2-phosphate, 2 mM L-glutamine, 100 
units/ml penicillin, 100 µg/ml streptomycin, then grown under standard cell 
culture conditions. As opposed to BMSCs, the DPSCs did not take up the 
Vybrant DiD dye to allow uniform staining, thus their proliferation was 
followed up with UV-VIS spectrophotometer (BIOTEK Powerwave XS) 
using Alamar Blue assay (Biosource, Invitrogen, USA). 
 The lineage specificity of cells was confirmed by the presence of 
lineage-specific cell surface markers with flow cytometry (BD® FacsCalibur, 
Becton Dickinson, NJ, USA). Haematopoietic lineage-specific surface 
markers (CD34, CD45) and mesenchymal surface markers (CD73, CD90, 
CD105 and CD166) were investigated.  
 The mesenchymal stem cells (MSCs) were seeded onto the surface 
of the bone grafts by two methods, i.e. A) under standard cell culture 
conditions; and B) under dynamic cell culture conditions: 
 A) The MSCs had been trypsinized and suspended in culture 
medium then applied with pipette to the surface of the test and control bone 
grafts (100.000 cells per graft). After seeding, the cells were expanded on 
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the bone grafts under standard cell culture conditions for 18 days and their 
proliferation was investigated at the 3rd and 18th days. 
 B) First, 100.000 cells per scaffold were seeded on the surface of 
bone grafts and stored under standard culture conditions for 24 hours. 
Following the incubation period, the bone grafts were placed into a 
bioreactor tube, which had been filled with 25 ml cell culture medium 
comprising 1,5 million MSCs in suspension. The bone grafts had been 
incubated in bioreactor under dynamic cell culture conditions for 24 hours 
then the cells were further expanded on the surface of bone grafts under 
standard culture conditions for 18 days. The viability and quantity of 
attached MSCs on the surface was investigated after 3 and 18 days of 
incubation.  
 The survival of the fluorescent dye labelled BMSCs was observed 
with confocal microscopy (LSM 510 META, Zeiss) on the surface of 
control and test groups. Three individual view fields were randomly 
selected on the surface of the grafts where the quantity of pixels belonging 
to the fluorescent BMSCs was measured.  
 The cell culture medium of DPSCs was supplemented with 
10w/w% AlamarBlue containing medium, which other components were 
identical to the normal culture medium of the cells. The bone grafts were 
incubated in this medium for 4 hours in cell culture incubator under 
standard cell culture condition. After incubation 200 µl of supernatant was 
pipetted into 96-well plate and the absorbance was measured at 570 nm and 
600 nm wavelengths. 
 Test A and Test B subgroups (Table 1) were investigated in an 
observational study with longitudinal design where the mutual exposure was 
cell seeding onto the surface of bone grafts and the survival (effect of the 
exposure) of the seeded cells was measured at two time points during the 
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experiments, i.e. 3rd and 18th days. The possible outcomes of the exposure 
were classified according to pre-set verification criteria that also constituted 
the basis of the evaluation of the performance of the bone grafts in the 
course of the in vitro study (Table 2). Only those grafts were further 
investigated in vivo animal studies that facilitated the long-term survival and 
proliferation of the MSCs in the in vitro experiments.  
 Repeated measures one-way ANOVA analysis was performed 
(Tukey’s post hoc test) to compare the quantity of MSCs on the scaffolds. A 
p value < 0.05 was considered significant. 
 
Table 2. Verification criteria to evaluate the in vitro performance of coated bone grafts. 
Those bone grafts were progressively excluded from further investigations that did not 
facilitate the adherence or proliferation compared to their uncoated counterparts. Those bone 
grafts were excluded from further experiments that felt into at least one exclusion category. 
 Baseline  Decrease Stagnate Increase 
Adherence 
Quantity of 
attached cells on 
uncoated bone 
grafts 






Does not affect 













of cells on 
uncoated bone 
grafts 





Does not affect 
the proliferation 
rate compared to 
baseline 
Exclude 






3.3. In vivo biocompatibility study of coated human bone grafts 
 The Institutional Review Board of Semmelweis University 
approved the surgical protocol of the animal study. The investigation of the 
in vivo biocompatibility of the coated bone grafts was carried out in a 
nonunion model, where the self-healing potential of the bone was 
compromised. Adult male Wistar rats (n=39) weighing 496–692g were 
housed and maintained at 12/12 day/night cycles and were provided with 
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water and lab chow ad libitum. The animals were anaesthetized with 
halothane in a 1:1 mixture of N2O and O2. The surgical site on the thigh 
around the femur was shaved and disinfected. The skin, the subcutaneous 
layer and the fascia were incised, the tensor fascia latae, and the vastus 
lateralis muscles were separated from the biceps femoris muscle. The femur 
was exposed from the hip joint to the knee, with special care to preserve the 
periosteum. A 5 hole steel plate (Mini plate; Sanatmetal, Eger, Hungary) 
was fixed to the diaphysis of the femur by four 1.5 mm wide and 8 mm long 
cortical screws (Sanatmetal, Eger, Hungary) using two proximal and two 
distal holes, while leaving the middle hole empty. After fixing the plate by 
the screws, an osteoperiosteal segment was removed at the level of the 
middle hole using a reciprocating saw (Electric Pen Drive, Synthes GmbH, 
Oberdorf, Switzerland). The bone was cut precisely through both cortical 
layers together with the periosteum. The size of the defect was 2 mm, where 
a preformed thick surgical-grade sterile PMMA (Heraeus Medical, 
Wehrheim, Germany) bone cement spacer was interposed for four weeks. 
The PMMA spacer was secured to the plate by 3-0 non-absorbable sutures 
to avoid displacement. Then, the muscle lobes were stitched by 3-0 
interrupted absorbable sutures over the femur, and the skin was closed by 3-
0 interrupted nylon sutures. After 4 weeks a second procedure was 
performed to allow bone grafting. In the first step, the sutures were removed 
and the femur was exposed as previously described. Then the PMMA spacer 
was removed and the defect was either left empty, or filled with an uncoated 
or a freeze-dried albumin coated bone human bone graft block. After graft 
insertion the wound was closed in the same manner as detailed earlier. 
Following 4 weeks the animals were sacrificed by exsanguination under 
anaesthesia and the femora were harvested. The development of a 
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union/nonunion was evaluated by µCT (Skyscan 1172 X-Ray 
microtomograph, Kontich, Belgium).  
 
4. Results 
4.1. In vivo biocompatibility of chemically sterilized, antigen extracted 
freeze-dried human bone graft  
Figure 1 (upper image on Panel a) shows that the defect was completely 
filled with PMMA and no bone formation was observed. In the vertebrae 
filled with human bone chips no or slow resorption was observed, and 
limited bone healing (bottom image on Panel a). In case of pCPC, in the 
vertebrae (middle image on Panel a) new bone formation was observed 
(white arrow). Bone defects without any spacer or filling showed good bone 
regeneration with new trabecular bone being formed in each sample 
providing a defect union rate of 100% (Figure 1, Panel b). In the delayed 
healing group, where the spacers were removed at 12th weeks and the defect 
was left empty for an 
additional 12 weeks, bone 
formation was observed in 
three defects while no or very 
limited bone formation was 
observed in the remaining four 
defects, where the union rate 
was 43% (Figure 1, Panel c). 
The µCT images demonstrated 
that trabecular bone was formed in the defects filled with SrCPS with a 
union rate of 80% with four defects being completely filled with new bone 
while in one specimen bone was formed, but it did not fill the entire defect 
(Figure 1, Panel d).  
 
Figure 1: shows the representative micro-CT 
images after 12 weeks of the operated 
vertebra.  
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The histological assessment 
showed that there was some 
bone formation in the bone 
chip group; however the 
bone chips are still 
demarcated from the bone. 
In the histology image bone 
chips are seen to have direct contact with newly formed bone (Figure 2). In 
contrast, the histological assessment confirmed that the SrCPS and pCPC 
had good biocompatibility and at the time of observation there were no 
visible signs of remaining SrCPS particles at light microscopy level 
indicating that the material was resorbed and built into the newly formed 
bone stock (Figure 2).  
4.2. Physical characteristics of coated bone grafts and in vitro 
adherence and proliferation of MSCs thereon 
 The SEM analysis revealed significant differences in the macro-, 
and microstructure of freeze-dried human bone allograft, hydroxyapatite 
and lyophilized bovine bone (BioOss) (Figure 3). Hydroxyapatite exhibited 
the most compact structure with low number of micro-pores. In contrast, the 
texture of lyophilized bovine bone was rich in large diameter channels. The 
freeze-dried cancellous allogeneic bone graft exhibited segmented surface 
with pores of various sizes. The coating of the surface of bone grafts with 
freeze-dried albumin amorphous protein flakes masked the original 
structural differences. The albumin flakes showed the most homogeneous 
distribution on the surface of Bio-Oss, whereas the continuity of the 
albumin flakes was disrupted with random uncoated areas on allografts. 
 The xenogeneic BioOss showed the lowest Vickers-hardness (14,9 
HV ± 4,1). The allogeneic bone graft showed higher values (55,1 HV ± 7,7) 
 
Figure 2: Representative hematoxylin and eosin 
stained histological section of the distal end of rat-tail 
vertebra after 12 weeks of normal healing and 
SrCPS, pCPC and human bone graft implantation. 
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than BioOss, whereas the synthetic hidroxiapatite was a magnitude harder 
than the other two grafts (320,4 HV ± 44,6). The micro-hardness values of 
freeze-dried albumin coated and uncoated allogeneic bone grafts were very 
similar (55.1N ± 7.7 vs. 53.9N ± 7.9, respectively). 
 
 
Figure 3. Macro- and 
microstructure of 
freeze-dried albumin 
coated and uncoated 
bone grafts. Scanning 
electron microscopy 
shows significant 
differences in the texture 
of allograft, 
hydroxyapatite (HAP), 
and lyophilized bovine 
bone graft (BioOss). 
Hydroxyapatite has the 
most compact structure 
with low porosity. On the 
other hand, high 
connectivity and thin 
wall-thickness typifies 
BioOss. The structure of 
human bone allograft is 
different from the other 
two. It is more compact 
than BioOss and its 
surface contains multiple 
micro-pores. By coating 
the surface of bone grafts 
with albumin amorphous 
protein chips mask the 
apparent differences in 
the micro- and 
nanostructure. 
 	   The coating of the surface of allografts with aqueous collagen or 
fibronectin slightly increased the initial adherence of BMSCs compared to 
the uncoated control, but the quantity of the cells was decreasing between 
the 3rd and 18th days of the experiments (Figure 4). In contrast, the albumin 
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coating of the surface of allografts markedly improved the initial adherence 
of BMSCs, however the cells disappeared from the surface by the 18th day 
(mean of pixels at the 3rd day: 2373 ± 142; at the 18th day: 0) 
 
 
Figure 4. Adherence and proliferation of BMSCs on the surface of allogeneic bone grafts 
coated with aqueous proteins. The bar diagram shows that coating of allografts with aqueous 
albumin resulted in high cell density at day 3 (p* < 0.05), whereas fibronectin and collagen 
slightly increased the initial cell adherence. Irrespective to the composition of aqueous coating 
proteins only a few cells were detectable on the surface of allografts at day 18. Panels A-B 
show representative confocal microscopic images of uncoated allografts (blue) with Vybrant-
DiD labelled BMSCs (red). The few observed cells on the surface at day 3 diminished even 
more by the 18th day. 
 
 
 Freeze-drying of serum albumin onto the surface of allografts 
reversed the tendency, thus the adhered BMSCs remained on the surface 
and showed moderate proliferation during the 18 day long experimental 
period (mean of pixels at the 3rd day: 1658 ± 278; mean of pixels at the 18th 
day: 2082, ± 110; p < 0.05). Interestingly, the freeze-drying of fibronectin 
and collagen onto the surface of allografts did not affect positively either the 
initial adherence or the proliferation BMSCs compared to allografts coated 
with the aqueous form that of proteins (Figure 5). 
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Figure 5. Adherence and proliferation of BMSCs on the surface of bone allografts coated 
with freeze-dried proteins. The bar diagram shows that freeze-drying of albumin onto the 
surface of bone allografts significantly increased the quantity of initially adhered cells at day 3 
compared to freeze-dried collagen or fibronectin coating. However, the multiplication of the 
adhered cells was moderate on the surface of freeze-dried albumin coated allografts during the 
experimental period. Panel A-B show representative images of freeze-dried albumin coated 
bone. The proliferation of the attached cells was observed on the day 18. 
 
 Dynamic seeding significantly increased the quantity of initially 
adhered BMSCs on the surface of the freeze-dried albumin coated allografts 
(Figure 6) compared to the standard culture conditions and the adhered cells 
showed intense proliferation (mean of pixels under standard condition at 
day 1: 197±23, under dynamic conditions at day 1: 9825±1208; at the 7th 
day: 15025±1704). The same tendency was observed when DPSCs were 
seeded on the surface of freeze-dried albumin coated allografts under 
dynamic and standard culture conditions (standard condition: mean of 
reduced Alamar Blue (%) at 3rd day: 14.5±2.23; mean at 7th day: 33.7±0,06; 
dynamic condition: mean of reduced Alamar Blue (%) at 1st day: 
33.5±2.23; mean at 7th day: 60.9±1,09).  
 
Figure 6. Attachment of BMSCs and DPSCs onto the surface of freeze-dried albumin 
coated allografts under dynamic conditions. The dynamic cell culture conditions markedly 
improved the initial attachment (p† < 0.05) of both BMSCs (A) and DPSCs (B) which retained 
their capability of proliferating (p*< 0.05).  
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4.3. Osseointegration of freeze-dried human serum albumin coated 
human bone graft 
 Implantation of albumin coated bone grafts into a segmental bone 
defect model of delayed bone healing resulted in better integration of the 
freeze-dried albumin coated grafts than the uncoated ones. The implanted 
grafts were located in the defect in each case, but only the freeze-dried 
albumin-coated grafts triggered the ingrowth of new bone from the bone 
ends resulting in the union of the defect (Figure 7). 
Figure 7. Reconstructed 3-dimensional 
µCT images of osteotomized rat femurs 
after 4 weeks of the grafting procedure. 
The left column shows that without freeze-
dried albumin coating the allogeneic human 
bone graft does not coalesce with the bone 
ends and there is no bony consolidation. In 
contrast, when the grafts were coated with 
albumin there was apparent bone 





 The results show that the in vivo biocompatibility of the chemically 
sterilized, antigen extracted freeze-dried human bone grafts is inferior to the 
comparator synthetic bone substitutes.	   The results supported that human 
serum albumin is a suitable coating substance to enhance the biological 
performance that of human bone grafts in in vitro and in vivo experimental 
settings. The freeze-drying procedure supports the reproducible biological 
performance of albumin coating, however, the homogeneity of albumin 
flakes is poor between the trabeculae of the human bone graft. The albumin 
coating does not influence the microhardness of the freeze-dried allografts; 
collagen I and fibronectin was not appropriate to
supply the long-term attachment and proliferation of
MSCs. It is possible that the mineralized surface of
freeze-dried human bone allograft does not contain ad-
equate binding ligands which can permanently anchor
collagen I and fibronectin. Under physiologic bone for-
mation, collagen, and other structure proteins first
build up the texture of the bone tissue followed by
mineral deposition. Therefore it is not surprising that
working in the opposite direction, that is, putting
structure proteins on top of a mineralized scaffold does
not yield optimal results.25
When the cells are seeded on the surface of freeze-
dried albumin coated allograft the protein absorbs
water and creates a miroenvironment for MSCs with
high local albumin content. Since serum is a well-
known supporting agent for cell proliferation, this
microenvironment probably increases the viability of
freshly deposited cells. These cells then easily regain
their metabolic activity and start to deposit their own
biofilm which further supports proliferation. The
human bone structure and pore size play a crucial role
in this mechanism. As it was observed in our electron
microscopic images, MSCs are not forming a monolay-
er on the surface of bone but rather span the pores
and establish minimal con ac wi h the surface. This is
in stark contrast to cell culture in traditional 2D
monolayers on plastic surfaces and possibly explains
why the proliferation-inducing properties of serum
outweigh attachment factors. The larger pore size of
lyophilized bovine bone graft or the smaller pores on
the surface of synthetic hydroxyapatite do not provide
optimal spatial arrangements for the MSCs. The lack
of cell proliferation on other graft materials further
supports this explanation. This mechanism provides
an opportunity to coloniz the surface of freeze-d ied
allografts in a simple rotating bioreactor system,
which is frequently used in clinical tissue-engineering
applications. In addition to bone marrow, proliferation
of dental pulp-derived derived MSCs was also
increased by albumin coating, making this technology
suitable for dental applications.
The preliminary in vivo testing of albumin coated
bone grafts showed an increased ingrowth on new
bone compared to the uncoated ones. This observation
highlights that early colonization of the graft with
Figure 5. In vivo biocompatibility of a bone graft with or without albumin coating. Reconstructed 3-dimensional mCT images are
shown of rat femora after 4 weeks of implantation of the graft. The left column shows that without albumin coating the bone graft does
not integrate into the bone ends and there is no bony consolidation. In contrast, when the grafts were coated with albumin there is
good ingrowth from the rat femur and a bony callous is formed.
Figure 6. Attachment and proliferation of BMSCs on the sur-
face of albumin coated and uncoated bone grafts. The coating of
hydroxyapatite (HAP) and lyophlized bovine bone (BioOss) with
freeze-dried human serum albumin does not improve the
attachment and proliferation of BMSCs on the surface of grafts
in contrast with mineralized bone allografts. !p < 0.05.
ADHERENCE AND PROLIFERATION OF MSCS 495
JOURNAL OF ORTHOPAEDIC RESEARCH MARCH 2012
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the agitation under dynamic culture condition does not reduce its biological 
value. Intriguingly, the albumin coating increases mainly the initial 
adherence of MSCs on the surface of allografts, whereas significant 
proliferation is only seen after seeding under dynamic culture conditions. 
After implantation into a nonunion site, albumin coating improved the 
ingrowth of new bone from the host and resulted in the union of the bone 
ends. Interestingly, the albumin coating does not improve the in vitro 
biocompatibility of either the lyophilized bovine bone or the synthetic 
hydroxyapatite bone scaffolds.  
 There might be common reasons behind the low incorporation rate 
and the low biocompatibility with MSCs of freeze-dried human bone 
allograft. The chemical treatment of allografts kills not only pathogenic 
microorganisms and reduce the quantity of antigens but destroys the 
osteoinductive and osteogenic molecules turning bone grafts into 
mineralized scaffolds with reduced biological value. Although the 
mechanism of action of albumin coating is not known, but we hypothesize 
that it may play a crucial role in the recruitment and activation of osteogenic 
cells based on the volume expansion (colloidal suspension) theory.  
 After bone replacement surgery, alike after injury when bony 
injury occurs, rapid and active inflammatory response floods the injury zone 
with blood cells, platelets, monocytes, macrophages and other cells of the 
inflammatory cascade. The result of this process is that the injury site gets 
isolated from the rest of the body, becoming avascular to insure that the 
local injury environment does not propagate to the rest of the body. These 
segregation processes that occur at the bone fracture or injury sites 
eventually result in the repair blastema and outer surrounding reparative 
callus. The fracture hematoma has been proven to be a source of signalling 
molecules, such as interleukins, tumour necrosis factor-α, fibroblast growth 
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factor, insulin-like growth factor, platelet-derived growth factor, vascular 
endothelial growth factor, and the transforming growth factor β superfamily 
members that are supposed to induce a cascade of cellular events that 
initiate healing. These signal molecules might be adsorbed by the colloidal 
suspension of albumin that increases the local concentration of such 
biological cues, while it provides a natural delivery system that allows the 
prolonged release of those signals. This assumption is based upon the high, 
non-selective affinity of serum albumin to bind various biomolecules 
creating a high capacity natural buffer (reservoir) for them. The increased 
local concentration and sustained availability of those soluble cues may 
enhance cellular events in the repair tissue allowing the union of the bone 
ends in our animal model when the self-healing ability of the bone was 
compromised.  
 The same volume expansion theory of albumin may explain the in 
vitro performance of freeze-dried albumin coating. It seems to be a possible 
explanation that freeze-dried albumin adsorbs water when the cells are 
seeded onto the surface of allografts in aqueous media. The water 
adsorption may trigger the volume expansion of albumin yielding colloidal 
suspension that is temporally trapped in the channels of the allograft due to 
its high viscosity. This colloidal suspension of albumin may embed MSCs 
and keep them in the pores and channels of the allograft providing enough 
time to produce extracellular matrix and establish focal adhesions with the 
surface.  
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6. Conclusions 
6.1. Chemically sterilized, antigen-extracted freeze-dried human bone grafts 
showed reduced in vivo osseointegration in compromised bone defect model 
compared to synthetic bone fillers.  
6.2. Freeze-dried human serum albumin is a suitable substance for the 
reproducible coating of cancellous human bone grafts. 
6.3. The freeze-dried human serum albumin coating improved the in vitro 
and in vivo biocompatibility of the chemically sterilized, antigen-extracted 
human bone grafts.  
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